Amyloid β protein impairs motor function via thromboxane A2 in the rat striatum-Reference-Cited by-同舟云学术

Amyloid β protein impairs motor function via thromboxane A2 in the rat striatum

Published:2004-08 Issue:3 Volume:16 Page:481-489
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Yagami Tatsurou,Takahara Yukio,Ishibashi Chiyomi,Sakaguchi Gaku,Itoh Naohiro,Ueda Keiichi,Nakazato Hitoshi,Okamura Noboru,Hiramatsu Yoshiharu,Honma Tsunetoshi,Arimura Akinori,Sakaeda Toshiyuki,Katsuura Goro

Publisher

Elsevier BV

Subject

Neurology

Reference44 articles.

1. Relation of contraversive turning to unilateral release of dopamine from the nigrostriatal pathway in rats;Arbuthnott;Exp. Neurol.,1971

2. Characterization and localization of thromboxane A2 receptor in human and guinea-pig nasal mucosa using radiolabelled (+)-S-145;Arimura;Br. J. Pharmacol.,1998

3. Molecular cloning and characterization of the human prostanoid DP receptor;Boie;J. Biol. Chem.,1995

4. Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes;Braak;J. Neuropathol. Exp. Neurol.,1990

5. Modification of dyskinesias following the intrastriatal injection of prostaglandins in rodent;Costal;Br. J. Pharmacol.,1985

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SNPs in cytochrome P450 genes decide on the fate of individuals with genetic predisposition to Parkinson’s disease;Frontiers in Pharmacology;2023-08-04

2. A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects;Inflammopharmacology;2023-03-24

3. β‐Arrestin‐2‐ERK1/2 cPLA 2 α axis mediates TLR4 signaling to influence eicosanoid induction in ischemic brain;The FASEB Journal;2019-02-22

4. Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid;Journal of Cerebral Blood Flow & Metabolism;2019-01-07

5. 15-Deoxy-Δ12,14-prostaglandin J2 induced neurotoxicity via suppressing phosphoinositide 3-kinase;Neuropharmacology;2017-02